Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Brady Family Wealth LLC Sells 2,471 Shares of Johnson & Johnson $JNJ
05:08am, Sunday, 21'st Dec 2025
Brady Family Wealth LLC cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 7.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Com
Astoria Portfolio Advisors LLC. Lowers Holdings in Johnson & Johnson $JNJ
03:44am, Sunday, 21'st Dec 2025
Astoria Portfolio Advisors LLC. lowered its position in Johnson and Johnson (NYSE: JNJ) by 43.2% during the undefined quarter, according to the company in its most recent disclosure with the Securitie
Why a Minnesota Jury Ordered Johnson & Johnson To Pay $65.5 Million in Damages
04:41pm, Saturday, 20'th Dec 2025
Johnson and Johnson has been directed to pay $65.6 million to a Minnesota woman who was diagnosed with cancer following the use of their talcum powder.
What Retirement Really Looks Like With $2.5 Million in Savings
10:31am, Saturday, 20'th Dec 2025
For as long as most of us can remember, the idea of retiring with $2.5 million in the "bank," is something of a dream. The belief that this amount of money would guarantee decades of worry-free living
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
03:55am, Saturday, 20'th Dec 2025
A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the li
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
01:38am, Saturday, 20'th Dec 2025
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson
05:54pm, Friday, 19'th Dec 2025
ST. PAUL, Minn.--(BUSINESS WIRE)--A Minnesota jury awarded $65.5 million to a 37-year-old mother of three minor children after finding in her favor in a lawsuit against Johnson & Johnson, concluding t
First Look: Oracle leads TikTok JV, CPI cools, Nike drops
07:37am, Friday, 19'th Dec 2025
Stock News TikTok inks U.S. spinoff deal: Oracle (ORCL) and partners Silver Lake and MGX will take major stakes in a new TikTok U.S. venture, with U.S. data hos
Johnson & Johnson $JNJ Shares Bought by Czech National Bank
05:28am, Friday, 19'th Dec 2025
Czech National Bank grew its stake in shares of Johnson and Johnson (NYSE: JNJ) by 4.0% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The f
Johnson & Johnson $JNJ Shares Sold by Chesley Taft & Associates LLC
04:48am, Friday, 19'th Dec 2025
Chesley Taft and Associates LLC lowered its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 2.6% during the undefined quarter, according to its most recent 13F filing with the Securities and
Market Today: CPI Cools; Micron Lifts AI Stocks (MU)
05:35pm, Thursday, 18'th Dec 2025
Guru Stock PicksCI Select Canadian Equity Fund has made the following transactions:Reduce in TSX: ABX by 9.95%Sold out in TSX:DOLAdd in TSX: KEY by 27.62%New posi
FDA Approves J&J's New 5-Minute Injection For Lung Cancer
02:40pm, Thursday, 18'th Dec 2025
FDA approves Johnson and Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma treatment.
J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant
01:51pm, Thursday, 18'th Dec 2025
JNJ wins FDA approval for a subcutaneous version of Rybrevant, cutting treatment time to minutes and boosting convenience across NSCLC indications.
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
11:40am, Thursday, 18'th Dec 2025
J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.
Retirees Banking on Quarterly Income Choose HDV Over Growth Funds for Its Defensive Holdings
09:03am, Thursday, 18'th Dec 2025
When income matters more than growth, retirees turn to funds that deliver quarterly checks without volatility. The iShares Core High Dividend ETF (NYSEARCA:HDV) yields 3.3%, triple the S&P 500's 1.03%
